Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy. [electronic resource]
Producer: 20140604Description: 977-81 p. digitalISSN:- 1545-5017
- Abdominal Neoplasms -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Combined Modality Therapy
- Consolidation Chemotherapy
- Disease-Free Survival
- Follow-Up Studies
- Gene Amplification
- Genes, myc
- Hematopoietic Stem Cell Transplantation
- Hepatic Veno-Occlusive Disease -- chemically induced
- Humans
- Infant
- Kaplan-Meier Estimate
- Melphalan -- administration & dosage
- Myeloablative Agonists -- therapeutic use
- Neuroblastoma -- drug therapy
- Proportional Hazards Models
- Remission Induction
- Thoracic Neoplasms -- drug therapy
- Transplantation Conditioning
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.